SYNTAX I, SYNTAX II and SYNTAX III: From invasive to non-invasive assessment of Coronary Stenosis


Exhibitor: Patrick W. Serruys

Recorded by TV Med – June 8th, 2016 / SOLACI-SBHCI Congress 2016.

 

We value your opinion. You are more than welcome to leave your comments, thought, questions or suggestions here below.

More articles by this author

FFR, IVUS and OCT in Chronic Coronary Syndromes

Lecture given by Dr. Mario Araya (Chile) on FFR, IVUS and CTO in acute coronary syndromes at SOLACI-SBHCI'16, Rio de Janeiro, Brazil. Recorded by TV...

Use of IFR and Bioresorbable Stent in Complex Multivessel Disease

Location: Hospital dos Servidores do Estado (HSE). Operators: Valério Fuks, Marcus Lacativa, André Duque Estrada, Maria Cristina Ferreira. Chairpersons: Marcelo Antônio Cartaxo Queiroga Lopes, Constantino Gonzalez...

Complex coronary angioplasty in octogenarian

Location: Instituto Nacional de Cardiologia Laranjeiras. Operators: Sérgio Leandro, Luiz Kohn. Chairpersons:  Maria de Lourdes Montedonio Santos, Breno Oliveira Almeida. Panelists: Sérgio Martins Leandro, Rodrigo de Franco...

TAVR in Aortic Valve Stenosis with LOTUS

Operators: Alexandre Abizaid, Dimytri Siqueira, David Lebihan. Chairpersons: Martin Leon, José Eduardo Morais Rego Sousa. Panelists: José Armando Mangione, Josep Rodés Cabau, Fabio Sândoli de Brito...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....